A. Barkan

发表

Gene expression signature in adipose tissue of acromegaly patients

I. Hochberg, A. Saltiel, D. Bridges, 2014, BMC Bioinformatics.

Significant Benefits of AIP Testing and Clinical Screening in Familial Isolated and Young-onset Pituitary Tumors

Julian R. E. Davis, H. Randeva, R. Eeles, 2020, The Journal of clinical endocrinology and metabolism.

Growth Hormone Is Secreted by Normal Breast Epithelium upon Progesterone Stimulation and Increases Proliferation of Stem/Progenitor Cells

S. Pinder, G. Dontu, M. Wicha, 2014, Stem cell reports.

Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States

S. Melmed, M. Fleseriu, S. Neggers, 2022, Pituitary.

Guidelines for acromegaly management: an update.

P. Chanson, M. Vance, S. Melmed, 2009, The Journal of clinical endocrinology and metabolism.

Surgical debulking of pituitary adenomas improves responsiveness to octreotide lar in the treatment of acromegaly

P. Cappabianca, A. Mamelak, R. Fahlbusch, 2017, Pituitary.

Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults

P. Chanson, A. Hoffman, S. Melmed, 2008, Journal of endocrinological investigation.

Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers

S. Melmed, M. Gadelha, L. Nachtigall, 2023, Pituitary.

Women with prolactinomas presented at the postmenopausal period

C. Benbassat, I. Shimon, M. Bronstein, 2014, Endocrine.

Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time?

P. Chanson, S. Radovick, A. Mamelak, 2021, Journal of the Endocrine Society.

Surgical debulking of pituitary adenomas improves responsiveness to octreotide lar in the treatment of acromegaly

P. Cappabianca, A. Mamelak, R. Fahlbusch, 2017, Pituitary.